Résultat de recherche

Gene therapy of hemoglobinopathies: progress and future challenges.

Gene therapy targeting haematopoietic stem cells for inherited diseases:...

Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor...

An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell...

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing...

Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights...

Transcriptional, epigenetic and retroviral signatures identify regulatory...

Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte...

Financements

Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction...

Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps...

Deletion of the LTR enhancer/promoter has no impact on the integration...

Lentiviral vector integration in the human genome induces alternative splicing...

The GATA1-HS2 enhancer allows persistent and position-independent expression...

Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like...

FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity...

NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during...

Transcription factor binding sites are genetic determinants of retroviral...

In vivo selection of genetically modified erythroblastic progenitors leads...

Les équipes de l'Institut Imagine